Starbucks ends employee coverage for these medicines amid rising US health costs
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 10 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Mon, 10 August 2026
1 report- Times of India02:59first to report
Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular for obesity treatment. Other companies like Allina Health and PwC have also adjusted their coverage policies. However, Bank of America views GLP-1 coverage as a vital employee health investment.